BrightSpring Health Services, Inc. (BTSGU) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — BTSGU

Balance Sheet

(in billions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024
Cash & Equivalents	0.89	0.14	0.07	0.05	0.04	0.03	0.06
Accounts Receivable	1.11	1.01	0.97	0.98	1.03	0.98	0.99
Inventory	0.56	0.64	0.63	0.53	0.48	0.37	0.37
Total Current Assets	2.69	2.78	2.65	2.53	1.71	1.52	1.57
Property, Plant & Equipment	0.20	0.18	0.18	0.18	0.25	0.25	0.25
Goodwill	2.53	2.37	2.37	2.37	2.67	2.63	2.61
Intangible Assets	0.34	0.38	0.41	0.43	0.71	0.73	0.74
Total Non-current Assets*	3.52	3.27	3.30	3.32	4.08	4.08	4.08
Total Assets	6.21	6.05	5.94	5.85	5.79	5.61	5.66
Accounts Payable	1.09	0.95	0.97	0.87	0.78	0.67	0.66
Total Current Liabilities	1.55	1.55	1.51	1.46	1.26	1.15	1.24
Long-term Debt	2.50	2.52	2.53	2.54	2.66	2.61	2.56
Total Non-current Liabilities*	2.68	2.68	2.69	2.70	2.90	2.85	2.84
Total Liabilities	4.22	4.23	4.20	4.16	4.17	4.00	4.08
Retained Earnings	0.01	(0.11)	(0.16)	(0.19)	(0.23)	(0.23)	(0.25)
Total Stockholder Equity	1.98	1.82	1.74	1.69	1.61	1.60	1.57

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Total Revenue	3.61	3.55	3.33	3.15	2.88	3.05	2.91	2.73	2.58
Cost of Revenue*	3.13	3.14	2.94	2.77	2.54	2.63	2.50	2.34	2.21
Gross Profit	0.48	0.41	0.39	0.37	0.34	0.42	0.41	0.39	0.37
Selling, General & Admin	0.36	0.30	0.30	0.33	0.29	0.34	0.35	0.33	0.36
Total Operating Expenses	0.36	0.30	0.30	0.33	0.29	0.34	0.35	0.33	0.36
Operating Income	0.12	0.11	0.09	0.05	0.05	0.08	0.06	0.06	0.01
Interest Expense	0.04	0.04	0.04	0.04	0.04	0.05	0.06	0.05	0.07
Pretax Income	0.08	0.07	0.05	0.01	0.01	0.02	0.00	0.01	(0.07)
Tax Provision	0.01	0.02	0.01	0.00	-0.00	0.01	0.01	(0.01)	(0.02)
Net Income	0.15	0.08	0.06	0.03	0.03	0.02	(0.01)	0.02	(0.05)
Basic EPS	0.73	0.38	0.27	0.14	0.15	0.11	(0.04)	0.10	(0.26)
Diluted EPS	0.67	0.34	0.26	0.13	0.14	0.11	(0.04)	0.10	(0.26)

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Operating Cash Flow	122.94	231.56	107.94	49.08	101.60	90.61	27.25	(15.22)	(78.86)
Capital Expenditures	21.54	37.67	15.76	24.43	17.63	15.31	20.04	23.74	21.82
Free Cash Flow*	101.40	193.89	92.17	24.65	83.97	75.30	7.20	(38.97)	(100.67)
Investing Cash Flow	747.39	(233.88)	(23.76)	(23.24)	(24.19)	(15.78)	(35.83)	(57.69)	(30.94)
Financing Cash Flow	(70.02)	(50.50)	(13.11)	(8.24)	(86.02)	(49.55)	19.53	39.91	154.76

* Derived from reported values